title: Confirmation of high cytokine clearance by hemofiltration with a cellulose triacetate membrane with large pores: an in vivo study.
abstract: OBJECTIVE
  To confirm in vivo the hypothesis that hemofiltration with a large pore membrane can achieve significant cytokine clearance.
  
  
  METHODS
  We used a well-known animal model of endotoxinic shock (0.5 mg/kg of lipopolysaccharide from Escherichia Coli over a period of 30 mins). Six pigs were hemofiltrated for 3 hours with a large pore membrane (78 A pore, 80 kDa cut off) (Sureflux FH 70, Nipro, Osaka, Japan). The ultrafiltration rate was 45 ml/kg/min. Samples were taken from arterial, venous line and in the ultrafiltrate at T120 and T240. We measured concentrations of interleukin 6, interleukin 10 and albumin.
  
  
  RESULTS
  At T120 and T240, the IL-6 clearances were 22 +/- 7 and 15 +/- 3 ml/min, respectively. The IL-6 sieving coefficients were 0.97 and 0.7 at T120 and T240, respectively. At T120 and T240, the IL-10 clearances were 14 +/- 4 and 10 +/- 7 ml/min, respectively. The sieving coefficients were 0.63 and 0.45 at T120 and T240, respectively. The concentrations of IL-6 and IL-10 were the same at T0 and T240. At T60 and T240, the plasmatic albumin concentrations were 24 +/- 4 g/L and 23 +/- 4 g/L, respectively (p = 0.13).
  
  
  CONCLUSIONS
  In this animal model of endotoxinic shock, we confirm the high cytokine clearance observed when hemofiltration is applied to a large pore membrane. The loss of albumin seems negligible. The impact of such clearances on hemodynamic stability and survival remains to be proved.
authors.affiliation: Department of Nephrology, University of Liege, Liege - Belgium. pierre_delanaye@yahoo.fr
authors.forename: P
authors.initials: P
authors.lastname: Delanaye
authors.forename: B
authors.initials: B
authors.lastname: Lambermont
authors.forename: J-M
authors.initials: JM
authors.lastname: Dogné
authors.forename: B
authors.initials: B
authors.lastname: Dubois
authors.forename: A
authors.initials: A
authors.lastname: Ghuysen
authors.forename: N
authors.initials: N
authors.lastname: Janssen
authors.forename: T
authors.initials: T
authors.lastname: Desaive
authors.forename: P
authors.initials: P
authors.lastname: Kolh
authors.forename: V
authors.initials: V
authors.lastname: D'Orio
authors.forename: J-M
authors.initials: JM
authors.lastname: Krzesinski
mesh_terms: D000818:Animals; D002482:Cellulose / Q000031:analogs & derivatives* / Q000737:chemistry; D004926:Escherichia coli; D005260:Female; D006440:Hemofiltration / Q000295:instrumentation* / Q000379:methods; D016753:Interleukin-10 / Q000097:blood*; D015850:Interleukin-6 / Q000097:blood*; D008070:Lipopolysaccharides; D008297:Male; D008567:Membranes, Artificial; D012772:Shock, Septic / Q000628:therapy; D013552:Swine; D013997:Time Factors
chemical_list: D015850:Interleukin-6; D008070:Lipopolysaccharides; D008567:Membranes, Artificial; D016753:Interleukin-10; D002482:Cellulose; C024671:cellulose triacetate